covaxin
-
Covid-19: In the rush to declare an ‘Atmanirbhar vaccine’, is India playing with fire?
Scroll Staff
-
Bharat Biotech chief hits out at Serum Institute for claiming other Covid vaccines are ‘like water’
Scroll Staff
-
The big news: Centre-farmer talks fail again, next round on Friday, and nine other top stories
Scroll Staff
-
‘First they questioned soldiers’ valour’: BJP hits back at Congress as it questions vaccine approval
Scroll Staff
-
The big news: Two coronavirus vaccines cleared for emergency use in India, and 9 other top stories
Scroll Staff
-
Covid-19: Serum vaccine to be used in first phase, Bharat Biotech shot back-up, says AIIMS director
Scroll Staff
-
Coronavirus: Serum Institute, Bharat Biotech vaccines 110% safe, says DCGI after emergency approval
Scroll Staff
-
Coronavirus: Congress questions Covaxin’s approval before completing phase-3 trials
Scroll Staff
-
The big news: Expert panel clears Covaxin, Covishield for emergency use, and nine other top stories
Scroll Staff
-
Covaxin has drawn global attention, says ICMR
Scroll Staff
-
Coronavirus: Antibodies generated by Covaxin may persist for 6-12 months, says Bharat Biotech
Scroll Staff
-
Coronavirus: Centre needs to protect vaccine makers against lawsuits, says Serum Institute chief
Scroll Staff
-
Covaxin induces strong immune response, no serious adverse effects in phase 1 trial: Bharat Biotech
Scroll Staff
-
Covaxin efficacy determined 14 days post second dose, says Bharat Biotech as Anil Vij tests positive
Scroll Staff
-
The big news: Tackle climate change in holistic way, Modi says at G20 meet, and 9 other top stories
Scroll Staff
-
Coronavirus: Covaxin will be at least 60% effective, says Bharat Biotech
Scroll Staff
-
Coronavirus: Haryana minister Anil Vij becomes first volunteer in state to get trial dose of Covaxin
Scroll Staff
-
Coronavirus: Bharat Biotech begins phase 3 trials of Covaxin in India
Scroll Staff
-
Coronavirus: Centre to increase bed count, double tests conducted daily in Delhi
Scroll Staff
-
Coronavirus: Covaxin could be available as early as February, says ICMR scientist
Scroll Staff